Synthetic Biology Overview

Principles

Definition

Synthetic biology is an interdisciplinary research field focused on the design, construction, and re-engineering of biological components, devices, and systems that do not exist in nature, or the modification of existing biological systems for novel applications. It employs engineering principles and methodologies to create predictable and controllable biological functions, aiming to advance both fundamental biological understanding and the development of biotechnological solutions.

Ontological type

Applications

Core Methods

Genetic Circuit Design

Key developments

Key Figures

Cell-Free and Modular Cloning era

Tom Maniatis [1], affiliated with Harvard University [3] and the California Institute of Technology [4], stands as a pivotal figure in establishing cell-free prototyping and standardized cloning workflows during this era. His 1984 paper Efficient in vitro synthesis of biologically active RNA and RNA hybridization probes from plasmids containing a bacteriophage SP6 promoter [6] demonstrated robust in vitro transcription-translation capabilities that enabled rapid testing of genetic elements outside cells, a cornerstone of the era's design-build-test cycle. Paul Berg [2], associated with Harvard University [3] and the Massachusetts Institute of Technology [5], contributed foundational insights at the interface of DNA-directed manipulation during this period. His 1962 work DEOXYRIBONUCLEIC ACID-DIRECTED SYNTHESIS OF RIBONUCLEIC ACID BY AN ENZYME FROM ESCHERICHIA COLI [7] established the DNA-directed synthesis of RNA, a mechanistic breakthrough that underpins later cell-free transcription systems and standardized cloning concepts central to this era.

PCR-Enabled Modular Engineering era

Thomas A. Kunkel [1] worked at Stanford University [3] and The University of Texas Southwestern Medical Center [4] during the PCR-Enabled Modular Engineering era. Kunkel [1] authored the paper Rapid and efficient site-specific mutagenesis without phenotypic selection [7], a result that established a practical route to targeted sequence changes and enabled iterative library construction, central to the era. Stephen B. H. Kent [2] conducted work at Rockefeller University [5] and University of California, San Francisco [6] during this era. Kent [2] contributed the Synthesis of Proteins by Native Chemical Ligation [8], a method enabling modular, multi-gene assembly and rapid testing that helped define the PCR-enabled modular engineering approach.

CRISPR-Driven Programmable Engineering era

Jennifer A. Doudna[1] is a pivotal figure in CRISPR biology, with affiliations at Innovative Genomics Institute[3] and University of California, San Francisco[4] during this era. Her 2012 paper A Programmable Dual-RNA–Guided DNA Endonuclease in Adaptive Bacterial Immunity[7] introduced programmable RNA-guided DNA cleavage, enabling targeted genome editing across organisms and catalyzing a shift toward sequence-directed design, while the 2015 paper Conformational control of DNA target cleavage by CRISPR–Cas9[8] clarified how conformational dynamics regulate cleavage and guided subsequent improvements in precision and delivery. Feng Zhang[2] rose as a leading figure, with affiliations at Harvard University[5] and the Institute of Cognitive and Brain Sciences[6] during this era. His in vivo genome editing using Staphylococcus aureus Cas9[9] extended CRISPR editing to compact Cas9 variants suitable for delivery, C2c2 is a single-component programmable RNA-guided RNA-targeting CRISPR effector[10] for RNA targeting, and RNA targeting with CRISPR–Cas13[11] further expanded programmable RNA manipulation, collectively broadening the CRISPR toolbox for genome and transcriptome engineering in diverse organisms.